×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Faculty of Healt... [6]
Authors
ZHAO QI [1]
Document Type
Journal article [6]
Date Issued
2024 [1]
2023 [3]
2022 [1]
2021 [1]
Language
英語English [6]
Source Publication
Cell [1]
Cell Discovery [1]
Med [1]
NATURE IMMUNOLOG... [1]
PLoS Pathogens [1]
Proceedings of t... [1]
More...
Indexed By
SCIE [5]
ESCI [1]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-6 of 6
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
Neutralization of EG.5, EG.5.1, BA.2.86, and JN.1 by antisera from dimeric receptor-binding domain subunit vaccines and 41 human monoclonal antibodies
Journal article
He, Qingwen, An, Yaling, Zhou, Xuemei, Xie, Haitang, Tao, Lifeng, Li, Dedong, Zheng, Anqi, Li, Linjie, Xu, Zepeng, Yu, Shufan, Wang, Ruyue, Hu, Hua, Liu, Kefang, Wang, Qihui, Dai, Lianpan, Xu, Kun, Gao, George F.. Neutralization of EG.5, EG.5.1, BA.2.86, and JN.1 by antisera from dimeric receptor-binding domain subunit vaccines and 41 human monoclonal antibodies[J]. Med, 2024, 5(5), 401-413.e4.
Authors:
He, Qingwen
;
An, Yaling
;
Zhou, Xuemei
;
Xie, Haitang
;
Tao, Lifeng
; et al.
Favorite
|
TC[WOS]:
3
TC[Scopus]:
4
|
Submit date:2024/05/16
Ba.2.86
Eg.5
Eg.5.1
Immune Evasion
Jn.1
Neutralizing Antibody
Rbd-dimer
Sars-cov-2
Translation To Humans
Zf2001 Vaccine
Zf2202-a
Defining a de novo non-RBM antibody as RBD-8 and its synergistic rescue of immune-evaded antibodies to neutralize Omicron SARS-CoV-2
Journal article
Rao, Xia, Zhao, Runchu, Tong, Zhou, Guo, Shuxin, Peng, Weiyu, Liu, Kefang, Li, Shihua, Wu, Lili, Tong, Jianyu, Chai, Yan, Han, Pu, Wang, Feiran, Jia, Peng, Li, Zhaohui, Zhao, Xin, Li, Dedong, Zhang, Rong, Zhang, Xue, Zou, Weiwei, Li, Weiwei, Wang, Qihui, Gao, George Fu, Wu, Yan, Dai, Lianpan, Gao, Feng. Defining a de novo non-RBM antibody as RBD-8 and its synergistic rescue of immune-evaded antibodies to neutralize Omicron SARS-CoV-2[J]. Proceedings of the National Academy of Sciences of the United States of America, 2023, 120(52), e2314193120.
Authors:
Rao, Xia
;
Zhao, Runchu
;
Tong, Zhou
;
Guo, Shuxin
;
Peng, Weiyu
; et al.
Favorite
|
TC[WOS]:
8
TC[Scopus]:
9
IF:
9.4
/
10.8
|
Submit date:2024/01/02
Cryptic Epitope
Neutralizing Antibody
Omicron Ba.4/ba.5/bq.1.1/xbb Subvariant
Rbd-8
Sars-cov-2
Broad protective RBD heterotrimer vaccines neutralize SARS-CoV-2 including Omicron sub-variants XBB/BQ.1.1/BF.7
Journal article
Yanfang Zhang, Xinrui Kang, Sheng Liu, Pu Han, Wenwen Lei, Ke Xu, Zepeng Xu, Zhengrong Gao, Xuemei Zhou, Yaling An, Yuxuan Han, Kefang Liu, Xin Zhao, Lianpan Dai, Peiyi Wang, Guizhen Wu, Jianxun Qi, Kun Xu, George F. Gao. Broad protective RBD heterotrimer vaccines neutralize SARS-CoV-2 including Omicron sub-variants XBB/BQ.1.1/BF.7[J]. PLoS Pathogens, 2023, 19(9), e1011659.
Authors:
Yanfang Zhang
;
Xinrui Kang
;
Sheng Liu
;
Pu Han
;
Wenwen Lei
; et al.
Favorite
|
TC[WOS]:
3
TC[Scopus]:
3
IF:
5.5
/
5.5
|
Submit date:2023/10/10
Dosing interval regimen shapes potency and breadth of antibody repertoire after vaccination of SARS-CoV-2 RBD protein subunit vaccine
Journal article
Guo Shuxin, Zheng Yuxuan, Gao Zhengrong, Duan Minrun, Liu Sheng, Du Pan, Xu XiaoYu, Xu Kun, Zhao Xin, Chai Yan, Wang Peiyi, Zhao Qi, Gao George F., Dai Lianpan. Dosing interval regimen shapes potency and breadth of antibody repertoire after vaccination of SARS-CoV-2 RBD protein subunit vaccine[J]. Cell Discovery, 2023, 9(1), 79.
Authors:
Guo Shuxin
;
Zheng Yuxuan
;
Gao Zhengrong
;
Duan Minrun
;
Liu Sheng
; et al.
Adobe PDF
|
Favorite
|
TC[WOS]:
5
TC[Scopus]:
5
IF:
13.0
/
14.8
|
Submit date:2023/08/25
Protective prototype-Beta and Delta-Omicron chimeric RBD-dimer vaccines against SARS-CoV-2
Journal article
Xu, Kun, Gao, Ping, Liu, Sheng, Lu, Shuaiyao, Lei, Wenwen, Zheng, Tianyi, Liu, Xueyuan, Xie, Yufeng, Zhao, Zhennan, Guo, Shuxin, Tang, Cong, Yang, Yun, Yu, Wenhai, Wang, Junbin, Zhou, Yanan, Huang, Qing, Liu, Chuanyu, An, Yaling, Zhang, Rong, Han, Yuxuan, Duan, Minrun, Wang, Shaofeng, Yang, Chenxi, Wu, Changwei, Liu, Xiaoya, She, Guangbiao, Liu, Yan, Zhao, Xin, Xu, Ke, Qi, Jianxun, Wu, Guizhen, Peng, Xiaozhong, Dai, Lianpan, Wang, Peiyi, Gao, George F.. Protective prototype-Beta and Delta-Omicron chimeric RBD-dimer vaccines against SARS-CoV-2[J]. Cell, 2022, 185(13), 2265-2278.e14.
Authors:
Xu, Kun
;
Gao, Ping
;
Liu, Sheng
;
Lu, Shuaiyao
;
Lei, Wenwen
; et al.
Favorite
|
TC[WOS]:
84
TC[Scopus]:
87
IF:
45.5
/
49.0
|
Submit date:2022/08/02
Covid19 Vaccine
Delta Variant
Immunogen Structure
Omicron Variant
Rbd
Receptor-binding Domain
Sars-cov-2
Vaccine Protection
Variant Of Concern
Voc
Protective Zika vaccines engineered to eliminate enhancement of dengue infection via immunodominance switch
Journal article
Dai, Lianpan, Xu, Kun, Li, Jinhe, Huang, Qingrui, Song, Jian, Han, Yuxuan, Zheng, Tianyi, Gao, Ping, Lu, Xuancheng, Yang, Huabing, Liu, Kefang, Xia, Qianfeng, Wang, Qihui, Chai, Yan, Qi, Jianxun, Yan, Jinghua, Gao, George F.. Protective Zika vaccines engineered to eliminate enhancement of dengue infection via immunodominance switch[J]. NATURE IMMUNOLOGY, 2021, 22(8), 958-968.
Authors:
Dai, Lianpan
;
Xu, Kun
;
Li, Jinhe
;
Huang, Qingrui
;
Song, Jian
; et al.
Favorite
|
TC[WOS]:
24
TC[Scopus]:
26
IF:
27.7
/
28.3
|
Submit date:2021/12/08